Mplx (NYSE:MPLX) Announces Earnings Results, Beats Expectations By $0.02 EPS
9 Articles
9 Articles
Mplx (NYSE:MPLX) Announces Earnings Results, Beats Expectations By $0.02 EPS
Mplx (NYSE:MPLX - Get Free Report) issued its quarterly earnings results on Tuesday. The pipeline company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. The business had revenue of $3.27 billion during the quarter, compared to analyst estimates of $3.35 billion. Mplx had a net margin of 35.75% and a return on equity of 32.83%.
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Key PointsPfizer's numbers were strong in its most recent quarter, with both its top and bottom lines coming in better than analyst forecasts.The company experienced 32% growth from launched and acquired products, highlighting its underrated growth potential.Its valuation remains modest, despite the stock's strong gains this year.Motley Fool Issues Rare "Total Conviction" Buy Alert › On Tuesday, healthcare giant Pfizer (NYSE:PFE) reported its th…
Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall
Pfizer Inc. raised its full-year outlook after it outperformed in the third quarter, as growing demand for its newer medicines helped the drugmaker offset declining sales of its Covid products.
Pfizer Raises 2026 Revenue Forecast to 62-64 Billion
Pfizer beat third-quarter analyst estimates and raised its 2026 revenue and adjusted-earnings forecasts, as growth in several medicines largely offset falling COVID-product and Prevnar sales; investors are also watching cost cuts, upcoming drug exclusivity losses and its obesity pipeline. Its Indian subsidiary reported a sharp quarterly profit increase, driven partly by an exceptional gain from the sale of Minipress XL. · 21 sources across the spectrum on IJR News.
Gartner Increases Full Year Guidance
Gartner, Inc. (IT) increased full year 2026 revenues, adjusted EBITDA excluding divested operation, adjusted EPS, and free cash flow guidance. Adjusted EPS is projected at or above $14.65, revised from prior guidance of at or above $14.00. Adj. EBITDA excluding Divested Operation is projected at or above $1.615 billion, revised from prior guidance of at or above $1.570 billion. Adj. revenues is now expected at or above $6.405 billion, updated fr…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium













